Canopy Growth Corp (CGC)
8.70
-0.27
(-3.01%)
USD |
NASDAQ |
Apr 25, 16:00
8.81
+0.11
(+1.26%)
After-Hours: 20:00
Canopy Growth Enterprise Value: 1.138B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 1.138B |
April 23, 2024 | 1.144B |
April 22, 2024 | 1.036B |
April 19, 2024 | 1.044B |
April 18, 2024 | 1.035B |
April 17, 2024 | 912.48M |
April 16, 2024 | 931.61M |
April 15, 2024 | 957.13M |
April 12, 2024 | 1.032B |
April 11, 2024 | 1.064B |
April 10, 2024 | 1.152B |
April 09, 2024 | 1.156B |
April 08, 2024 | 1.244B |
April 05, 2024 | 1.249B |
April 04, 2024 | 1.212B |
April 03, 2024 | 1.313B |
April 02, 2024 | 1.082B |
April 01, 2024 | 1.007B |
March 28, 2024 | 1.107B |
March 27, 2024 | 1.191B |
March 26, 2024 | 979.90M |
March 25, 2024 | 886.06M |
March 22, 2024 | 1.022B |
March 21, 2024 | 736.63M |
March 20, 2024 | 734.81M |
Date | Value |
---|---|
March 19, 2024 | 670.11M |
March 18, 2024 | 659.18M |
March 15, 2024 | 601.78M |
March 14, 2024 | 573.53M |
March 13, 2024 | 590.85M |
March 12, 2024 | 587.20M |
March 11, 2024 | 595.40M |
March 08, 2024 | 599.05M |
March 07, 2024 | 591.76M |
March 06, 2024 | 586.29M |
March 05, 2024 | 584.47M |
March 04, 2024 | 596.31M |
March 01, 2024 | 613.62M |
February 29, 2024 | 620.91M |
February 28, 2024 | 627.29M |
February 27, 2024 | 642.78M |
February 26, 2024 | 637.31M |
February 23, 2024 | 627.29M |
February 22, 2024 | 628.20M |
February 21, 2024 | 634.58M |
February 20, 2024 | 643.69M |
February 16, 2024 | 669.20M |
February 15, 2024 | 648.25M |
February 14, 2024 | 641.87M |
February 13, 2024 | 639.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
573.53M
Minimum
Mar 14 2024
19.17B
Maximum
Feb 10 2021
4.716B
Average
4.175B
Median
Enterprise Value Benchmarks
Tilray Brands Inc | 1.586B |
Clever Leaves Holdings Inc | 1.283M |
Flora Growth Corp | 14.14M |
Acasti Pharma Inc | 2.144M |
Aurinia Pharmaceuticals Inc | 376.94M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -159.25M |
Revenue (Quarterly) | 57.67M |
Total Expenses (Quarterly) | 75.97M |
EPS Diluted (Quarterly) | -1.925 |
Gross Profit Margin (Quarterly) | 35.95% |
Profit Margin (Quarterly) | -276.2% |
Earnings Yield | -173.7% |
Normalized Earnings Yield | -89.74 |